1. Validation of a Novel Diagnostic Kit Using the Semidry Dot-Blot Method to Detect Metastatic Lymph Nodes in Breast Cancer: Distinguishing Macrometastases From Nonmacrometastases
- Author
-
Megumi Matsumoto, Masayuki Baba, Hiroshi Hirakawa, Kenichiro Shibata, Masahiro Nakashima, Masahiro Oikawa, Toshiko Hatachi, Kuniko Abe, Hiroshi Yano, Hideki Taniguchi, Eiko Inamasu, Takeshi Nagayasu, and Ryota Otsubo
- Subjects
0301 basic medicine ,Cancer Research ,Pathology ,medicine.medical_specialty ,Time Factors ,Cost-Benefit Analysis ,Immunoblotting ,Dot blot ,Breast Neoplasms ,Lymph node metastasis ,Sensitivity and Specificity ,Metastasis ,03 medical and health sciences ,Cytokeratin ,0302 clinical medicine ,Breast cancer ,medicine ,Lavage fluid ,Humans ,Breast ,Prospective Studies ,Lymph node ,Keratin-19 ,Sentinel Lymph Node Biopsy ,business.industry ,Middle Aged ,medicine.disease ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,Neoplasm Micrometastasis ,Lymphatic Metastasis ,030220 oncology & carcinogenesis ,Axilla ,Female ,Lymph ,Sentinel Lymph Node ,business - Abstract
Background The semidry dot-blot method is a diagnostic procedure for detecting lymph node (LN) metastases using the presence of cytokeratin (CK) in lavage fluid from sectioned LNs. We evaluated 2 novel kits that use newly developed anti-CK-19 antibodies to diagnose LN metastases in breast cancer. Patients and Methods We examined 159 LNs dissected that we sliced at 2-mm intervals and washed with phosphate-buffered saline. The suspended cells in the lavage were centrifuged and lysed to extract protein. This extracted protein was used with a low-power and a high-power kit to diagnose LN metastasis. Diagnoses on the basis of the kits were compared with pathological diagnoses. Results Of the 159 LNs, 68 were assessed as positive and 91 as negative in permanent section examination. Sensitivity, specificity, and accuracy of the low-power kit for detecting LN metastases was 83.8%, 100%, and 93.1%, respectively. Those of the high-power kit were 92.6%, 92.3%, and 92.5%, respectively. Combining the low- and high-power kit results, those for distinguishing macrometastases were 94.5%, 95.2%, and 95.0%, respectively. Diagnosis was achieved in approximately 20 minutes, at a cost of less than $30 USD. Conclusion The kits were accurate, fast, and cost-effective in diagnosing LN metastases without the loss of LN tissue.
- Published
- 2018